ICTUImperial Clinical Trials Unit

Welcome to Imperial Clinical Trials Unit (ICTU)

This website is intended for people who are considering taking part in clinical trials and would like to find out more about what’s involved, why clinical trials are important and what the benefits of taking part in trials are. You can also find out about current clinical trials going on in ICTU and how to get involved.

Clinical Trials Search

OR

CurrentAll Trials

IRIS

Trial Details

  • Trial statusAnalysis
  • Study email contactiris-trial@imperial.ac.uk
  • Chief InvestigatorCarlo Palmieri
  • SponsorImperial College London
  • PhaseII

A Phase II study to assess the safety and efficacy of the steroid sulfatase inhibitor Irosustat when added to an aromatase inhibitor in ER positive locally advanced or metastatic breast cancer patient

Design and Objective

Primary Objective: To assess the efficacy of Irosustat when added to existing aromatase inhibitor (AI) therapy in patients who have progressed on an AI based on clinical benefit rate (CBR).

Key inclusion criteria

Written informed consent prior to admission to this study Aged ≥ 25 years of age Histologically confirmed ER+ve primary or metastatic breast cancer according to local criteria Locally advanced or metastatic breast cancer treated with 1st line AI treatment Postmenopausal ECOG performance status 0 to 2 Life expectancy of ≥ 3 months

Study Disclaimer Statement